SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a recent land sale agreement, which is expected to boost the company's NAV. The stock's low float is attracting attention, with community members anticipating a potential breakout and a significant price surge. Some traders are comparing it to other low-float stocks that have recently experienced parabolic runs.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

4Chan is trending as community members discuss its potential as the 'Bitcoin of Memecoins' and its ties to internet meme culture. Conversations highlight its community-driven nature and potential for significant gains, while some users are pointing to $GASH.X as another opportunity. There's also discussion around the influence of key figures and potential catalysts for future growth.

Hang Feng Technology Innovation Co Ltd

Hang Feng Technology Innovation Co ($FOFO) is trending due to a significant price surge, drawing comparisons to previous high-flying IPOs. Community members are debating whether the stock's movement is fundamentally driven or a result of speculative trading, with some expressing regret for missing earlier entry points while others highlight the potential for further gains. The stock's unusual behavior and rapid price appreciation are key topics of discussion among traders.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE.X is trending as its community rallies around the meme coin, expressing bullish sentiment and encouraging others to join before a potential surge. The community emphasizes hard work and persistence, alongside the coin's association with well-known figures in the crypto space. Discussions also highlight on-chain metrics and potential trend continuation.

Electronic Arts, Inc. engages in the development, marketing, publication, and distribution of games, content, and services for game consoles, PCs, mobile phones, and tablets. The company develops and publishes games and services across various genres, such as sports, first-person shooter, action, role-playing, and simulation primarily under the Battlefield, The Sims, Apex Legends, Anthem, Need for Speed, and Plants v. Zombies brands, and license games, including FIFA, Madden NFL, and Star Wars brands. The firm also provides advertising services and licenses its games to third parties to distribute and host its games. It markets and sells its games and services through digital distribution channels, as well as through retail channels, such as mass-market retailers, electronics specialty stores, and game software specialty stores. The company was founded by William M. Hawkins III and William Gordon in 1982 and is headquartered in Redwood City, CA.

Electronic Arts, Inc.

Electronic Arts stock is trending due to reports of a potential deal to go private, with a consortium including Silver Lake and Saudi Arabia's Public Investment Fund reportedly considering a roughly $50 billion acquisition. The community is discussing the potential impact on the company's strategy and game development, with some hoping for improvements in game quality if EA transitions away from public market pressures. Some traders are considering possible bidding wars and comparing EA's valuation to other gaming companies like Roblox.

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

BioAffinity Technologies Inc

BioAffinity Technologies is trending due to recent case studies highlighting the effectiveness of their CyPath Lung test in early lung cancer detection, potentially reducing the need for invasive procedures; community members are actively discussing buyout potential and comparing it to other runners. The stock is drawing attention as a low-float play with a focus on a non-invasive diagnostic approach in the large lung cancer market.

USELESS

$USELESS.X is gaining traction as community members highlight its potential for a parabolic run, drawing comparisons to other meme coins.  Whales accumulating $USELESS.X, and some believe it could even surpass established crypto projects. The coin's self-aware branding as 'completely useless' adds to its appeal within the speculative crypto market.

American Exceptionalism Acquisition Corp. A

American Exceptionalism Acquisition Corp. A ($AEXA) is trending as the community speculates on potential targets, with some eyeing opportunities in energy, AI, DeFi, and defense. Chatter suggests possible short covering, while others express hope for a deal with a popular website or anticipate involvement from a well-known figure in the SPAC space. Some traders are also discussing float dynamics and potential for a squeeze.

The centrifuge token model powers centrifuge, providing the framework needed to run the platform without reliance on a single point of failure, including the centrifuge team or Company, and to accelerate its utility. To accomplish this, centrifuge leverages the cryptoeconomic primitives of a native token called the centrifuge token (cfg), a nominated-proof-of-stake consensus algorithm that employs centrifuge to stake value, rewards for centrifuge adoption, and an on-chain governance mechanism that empowers centrifuge holders to guide the development of centrifuge.

Centrifuge

Centrifuge ($CFG.X) is gaining traction as a key player in the Real World Asset (RWA) tokenization space, with recent news highlighting partnerships for tokenized funds and credit facilities. The community is actively discussing its potential for high returns and its role in bridging traditional finance with DeFi. Recent integrations and launches are also driving interest in the project.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals ($ENTA) is trending as investors anticipate topline results from its Phase 2b study evaluating Zelicapavir for RSV treatment in high-risk adults, expected to be released soon. Community discussions revolve around potential outcomes and market impact, with some expressing skepticism while others remain optimistic. The broader context includes increased attention on biotech stocks with near-term catalysts and ongoing developments in the RSV antiviral space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Encompass Health Opens First Connecticut Rehab Hospital in Danbury

EHC opens its first Connecticut rehab hospital in Danbury, boosting its nationwide expansion and meeting rising demand for specialized care.

HRMY Stock Down as Fragile X Syndrome Study Fails to Meet Goal

Harmony Biosciences' shares plunge after ZYN002 failed in Fragile X, but Wakix sales and new epilepsy assets keep its pipeline moving forward.

Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

BMY Reports Positive Data From a Late-Stage Multiple Myeloma Study

Bristol Myers reports positive phase III results for iberdomide in multiple myeloma, advancing its CELMoD pipeline and portfolio expansion.

Powell Warns of Valuation Risks: 5 High Earnings Yield Value Picks 

Powell flags lofty valuations, but five high-earnings-yield stocks stand out as value picks in a cautious market.

Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience

Biotech stocks gain momentum as M&A, AI-driven drug discovery, and new approvals fuel growth; Halozyme, Akero, Kiniska, ANI and Twist stand out.

Halozyme Therapeutics and Synopsys have been highlighted as Zacks Bull and Bear of the Day

Halozyme shines with strong growth and partnerships, while Synopsys struggles after earnings miss and lowered outlook.

5 Biotech Stocks Worth Adding to Your Portfolio Now 

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position HALO, AKRO, KSNA, ANIP and TWST in this volatile sector

Bull of the Day: Halozyme Therapeutics (HALO)

The Street bailed on HALO in the spring, right before a summer rally to new highs on strong growth

Halozyme Therapeutics (HALO) Is Up 2.63% in One Week: What You Should Know 

Does Halozyme Therapeutics (HALO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Halozyme Therapeutics Inc.

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Current Price	$73.75
Prev Close	$73.97
Open	$74.72
Dividend Yield	0.00%
50-Day Moving Average	$68.33
Beta	0.69
Avg. Volume	2.2M
PE Ratio	16.90

52-Week High	$79.50
52-Week Low	$42.01
Market Capitalization	$8.65B
EPS (Annual)	$3.43
Price to Book	26.15
Revenue Per Employee	$2.9M
Enterprise Value/EBITDA	N/A

HALO
Halozyme Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HALO News

HALO Halozyme Therapeutics Inc.